insights_auto
为什么 AGIO 下跌了 2.33%?
深入探索chevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$37.23
arrow_downward
-2.33%(-0.89) 1 天
US$37.25
arrow_upward
+0.05% (+0.020)today开盘前
休市： 10月29日, GMT-4 16:00:01 · USD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 AGIO 生成关键数据洞见…
开盘价
US$38.23
最高价
US$38.69
最低价
US$36.76
市值
22.23亿
平均成交量
117.14万
成交量
1093.00
52 周最高价
US$45.99
52 周最低价
US$22.24
每股收益
-US$7.01
Beta 版
0.63
流通股数
5970.20万
员工人数
540
开盘价
US$38.23
最高价
US$38.69
最低价
US$36.76
市值
22.23亿
平均成交量
117.14万
成交量
1093.00
52 周最高价
US$45.99
52 周最低价
US$22.24
每股收益
-US$7.01
Beta 版
0.63
流通股数
5970.20万
员工人数
540
新闻报道
来自网络来源和新闻合作伙伴
Zacks
·
21小时前
Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Yahoo Finance
·
22小时前
Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Investing.com Nigeria
·
3天前
Form 144 AGIOS PHARMACEUTICALS For: 27 October By Investing.com
资料
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Agios Pharmaceuticals Inc简介